Neurological Manifestations in Stroke Patients: A Comparative Analysis of COVID-19 and Non-COVID-19 Cases

Background: Millions of individuals are being affected by the 2019 corona virus disease (COVID-19), which has spread globally. Although there is uncertainty regarding the origin and pattern of this association, certain neurological abnormalities, including stroke, have been reported in individuals with corona virus infection 2019 (COVID-19). Stroke and COVID-19 may be related; however, the exact nature of this connection is unknown. Aims: The aim of my study is to analyze and compare the neurological impairment between stroke patients with COVID-19 and those who are not. Methods: For this study, I followed PRISMA criteria to search published literature for data demonstrating clinical manifestations of stroke with and without COVID-19 reports. For published studies, the following databases were evaluated: PubMed, Google Scholar, Springerlink and Medline. Data were manually retrieved from research that qualified. Results & Conclusions: This narrative review explores the neurological manifestations in stroke patients affected by COVID-19 compared to those unaffected. Utilizing data from 30 studies, this review highlights the prevalence of ischemic strokes in COVID-19 patients, associated risk factors, and clinical symptoms. Findings suggest that COVID-19 intensifies the risk of cerebrovascular events through hypercoagulation and systemic inflammation, emphasizing the need for continuous monitoring and targeted interventions for stroke prevention in COVID-19 patients.